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Background: Transplantation of olfactory ensheathing cells (OEC) and Schwann cells (SC) is a promising
therapeutic strategy to promote axonal growth and remyelination after spinal cord injury. Previous studies mainly
focused on the rat model though results from primate and porcine models differed from those in the rat model.
Interestingly, canine OECs show primate-like in vitro characteristics, such as absence of early senescence and
abundance of stable p75NTR expression indicating that this species represents a valuable translational species for
further studies. So far, few investigations have tested different glial cell types within the same study under identical
conditions. This makes it very difficult to evaluate contradictory or confirmatory findings reported in various studies.
Moreover, potential contamination of OEC preparations with Schwann cells was difficult to exclude. Thus, it remains
rather controversial whether the different glial types display distinct cellular properties.
Results: Here, we established cultures of Schwann cell-free OECs from olfactory bulb (OB-OECs) and mucosa
(OM-OECs) and compared them in assays to Schwann cells. These glial cultures were obtained from a canine large
animal model and used for monitoring migration, phagocytosis and the effects on in vitro neurite growth. OB-OECs
and Schwann cells migrated faster than OM-OECs in a scratch wound assay. Glial cell migration was not modulated
by cGMP and cAMP signaling, but activating protein kinase C enhanced motility. All three glial cell types displayed
phagocytic activity in a microbead assay. In co-cultures with of human model (NT2) neurons neurite growth was
maximal on OB-OECs.
Conclusions: These data provide evidence that OB- and OM-OECs display distinct migratory behavior and
interaction with neurites. OB-OECs migrate faster and enhance neurite growth of human model neurons better than
Schwann cells, suggesting distinct and inherent properties of these closely-related cell types. Future studies will
have to address whether, and how, these cellular properties correlate with the in vivo behavior after transplantation.
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Neurons of the mammalian central nervous system have
a very restricted regenerative capacity in response to
damage [1,2]. The potential of creating a favorable cellu-
lar environment for improving neurological recovery
from traumatic spinal cord injury is currently a topic of
intense basic and clinical research [3]. Transplantation
of Schwann cells (SC) and olfactory ensheathing cells
(OEC) appears to be a promising therapeutic strategy to
facilitate axon regeneration and remyelination after spi-
nal cord injury. During lifelong sensory neuron turnover,
OECs continuously support axonal outgrowth from the
periphery into the olfactory bulb of the CNS. Due to
their potential to create a permissive environment for
axon growth and accessibility by nasal biopsy, OECs de-
rived from olfactory mucosa are considered to be com-
pelling candidates for autologous cell grafts [4]. Indeed,
in a recent study of Granger et al. on pet dogs with se-
vere chronic spinal cord injury, intraspinal transplan-
tations of OECs derived from the olfactory mucosal
cultures caused an improvement in fore limb-hind limb
coordination [5]. Several other transplantation studies
have used OECs or Schwann cells in models of spinal
cord injuries to restore myelination and promote axonal
regeneration [6-9]. Grafting of cultured olfactory en-
sheathing cells from the olfactory bulb into the spinal
cord promoted regrowth of lesioned long spinal axons
[6-8,10].
Migration into and beyond the site of lesion is a cri-
tical point to bridge the glial scar for creation of a per-
missive environment over the whole lesion site. Early
studies using Schwann cells from rat and mouse re-
ported extensive migration of transplanted cells into the
demyelinated regions of the lesion in the spinal cord
[11,12]. Since the migratory properties of glial cell trans-
plants contribute to the restoration of neuronal function
in the injured CNS, we investigated the cellular motility
of three purified glial types and evaluated whether moti-
lity could be up-regulated by application of cyclic nuc-
leotide signaling molecules [13] and a phorbol ester.
To promote axonal regeneration transplanted cells can
remove cellular debris of necrotic neurons and glia. Es-
pecially remaining myelin is a key factor of blocking
axonal regeneration [14]. Both, OECs and Schwann cells
are known to phagocytize bacteria as well as fragments
of degraded neurons, however reports of phagocytosis of
cellular debris after transplantation are still lacking
[15-17]. Thus we studied whether OECs and Schwann
cells can phagocytize microspheres in an in vitro co-
culture system.
Another important feature of this study is the estab-
lishment of a Schwann cell-free preparation as reported
[18]. The olfactory mucosa contains OECs and myelina-
ting Schwann cells from trigeminal afferents and othernon-myelinating cells. Moreover, the close phenotypic
resemblance of OECs and Schwann cells and the expres-
sion of marker molecules such as the neurotrophin re-
ceptor p75 (p75NTR) and glial protein S100 represent
obstacles for the selective identification and purification
of pure OEC preparations that are free of Schwann cells.
Using magnetic activated cell sorting, it has recently
been shown that contaminating Schwann cells can be
depleted from canine OEC preparations allowing further
in vitro characterization of purified OECs from olfactory
bulb (OB-OECs), olfactory mucosa (OM-OECs), and
Schwann cells from fibular nerve [18].
To advance our understanding how these various
groups of glial cells may facilitate axonal regeneration
in the damaged CNS various in vitro assays were per-
formed. Since a permissive environment created by trans-
plants of migratory glial cells contributes to axonal
outgrowth in the injured CNS, initially we investigated the
cellular motility of the purified three glial types. To com-
pare cell motility, a scratch migration assay which mea-
sures cell migration during the closure of a “wound” that
is scratched into a confluent cell monolayer was used. In
addition, it was investigated whether motility could be up-
regulated by chemical manipulation of intracellular sig-
naling cascades. So far, we found no evidence that glial
migration is influenced by application of cGMP or cAMP
signaling molecules [19,20], but activating PKC enhances
motility. Glial cells may aid repair processes in the CNS
by clearing cellular debris via phagocytosis. Using a phago-
cytosis assay, we demonstrated internalization of fluores-
cent microspheres into all three glial cell types.
Finally, glial cells were analyzed for their potential to
improve neurite outgrowth in a co-culture system with
human NT2 model neurons. These neurons were de-
rived from the Ntera2/D1 clone of a well characterized
teratocarcinoma cell line, which can be induced to dif-
ferentiate into fully functional post mitotic neurons by
retinoic acid treatment. NT2 cells resemble human em-
bryonic stem cells [21] and the differentiation of NT2
cells into neurons has been suggested to mimic aspects
of vertebrate neurogenesis [22-25]. The co-culture assays
using OECs and SCs represent a needed prerequisite to
evaluate the potential therapeutic impact of the three
glial cell types for repair of spinal cord injuries in a




One therapeutic aspect of OEC cell transplantation for
treatment of SCI is related to the glial ability to migrate
within the injury site and to accompany regenerating
neurites. To compare the motility of the purified canine
glial cells, we used a scratch migration assay which
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is scratched into a confluent cell monolayer (Figure 1A)
[26,27]. Immunocytochemical staining of purified cultures
confirmed p75 neurotrophin receptor (p75NTR) expression
in all types of glial cells (Figure 1B-D). High magnification
images depicted a patchy appearance of immunoreactivity
on the glial cell surface, indicative of selective membrane
incorporation under cell culture conditions. We seeded
the cells into 24-well-plates and performed a scratch
wound to the confluent cell monolayer using a pipette tip
(Figure 1A). Figures 1E and F show how a scratch wound
in a confluent layer of purified OECs from the olfactory
bulb induces glial migratory behaviour. The closure of the
gap was monitored by following the advancement of the
cell front over 8 h. Because this time interval is too short
for significant cell proliferation, presence of cells in the
gap largely reflects migration (Figure 1F). To estimate cell
proliferation in the scratch wound, we performed a BrdUFigure 1 Scratch wound assay to quantify and analyze migration rate
drawing of the scratch wound assay. Confluent cell monolayer (left drawin
the closure of the wound. The gap width is photographed at t0 and t8 and
of OB-OECs (B), OM-OECs (C) and Schwann cells (C stained for p75NTR and
process-bearing phenotype or a more flattened phenotype with only short
of the scratch at t0 and after 8 h migration are shown exemplarily for OB-O
showed significant higher migration rates than OM-OECs or Schwann cells
difference. Histograms present mean ± SEM of 7 (60 scratches, OB-OECs), 7
Statistical analysis was performed using an ANOVA and the Newman-Keuls
(red) and DAPI (blue). Scale bars are 50 μm (B-D) and 200 μm (E and F).assay [28] and found less than 20% BrdU-positive cells at
8 h of incubation.
All three glial cell types displayed migratory capability
and initiated wound closure. In the scratch assay, OB-
OECs (n: 60) migrate considerably faster than OM-OECs
(n: 58, 85.62% ± 2.337 of OB-OECs) and Schwann cells
(n: 46, 85.62% ± 1.733 of OB-OECs, Figure 1G).
Chemical manipulation of ensheathing cell migration
Protein kinases C have been identified as essential regu-
lators of migration in several cancer and epithelial cell
types as well as for human neural progenitors [29-32]. In
our motility assay, application of 1 nM of the protein
kinase C activator TPA (12-O-tetradecanoylphorbol-13-
acetate) resulted in a significant increase of cell migra-
tion for ensheathing cells from the olfactory bulb (136%
of control, Figure 2A) and the olfactory mucosa (144%
of control, Figure 2B). Raising the concentration to10of canine olfactory ensheathing and Schwann cells. (A) Schematic
g) is scratched using a pipette tip (middle). The right drawing shows
measured using ImageJ (red arrows) (B-D) Representative images
DAPI are shown. All cells displayed either a spindle-shaped and
processes emanating from the cell soma. (E-F) Representative images
ECs. (G) Migration rate differs after 8 h between cell types. OB-OECs
whereas OM-OECs and Schwann cells showed no significant
(48 scratches, OM-OECs) and 5 experiments (46 scratches, SCs).
post-hoc test (**p < 0.01, *p < 0.05). Cells are stained against p75NTR
Figure 2 Protein kinase C activator TPA enhances cell migration. (A) OB-OECs showed an increase of migration to 130% compared to
controls at 1 to 100 nM TPA in the scratch wound assay (B) Application of protein kinase C activator TPA to OM-OECs resulted in a significant
increase to 144% compared to controls at 1 nM TPA, however, no difference was observed at 10 and 100 nM (C) Schwann cells showed no
migratory effect after TPA treatment (D) NT2 precursor treated with TPA resulted in an increase of migration to approximately 200% compared to
controls. (E-G) Human NT2 precursor migration increased when treated with the PKC activator TPA (G) compared to the control (F). Histograms
present mean ± SEM of 3 (Schwann cells, OB-OECs and OM-OECs) and 5 experiments (NT2 precursor). Statistical analysis was performed using an
ANOVA and the Newman-Keuls post-hoc test (***p < 0.001, **p < 0.01). Scale bar is 200 μm.
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migration to 130% and 135% of control, respectively
(Figure 2A). However, migration rates of OM-OECs fall
back to control level at concentrations above 1 nM TPA.
Schwann cells were less responsive to the PKC activator,
showing no significant increase in cell migration
(Figure 2C). As additional migratory cell type we used
human NT2 precursor cells as positive control, repre-
senting an internal laboratory standard with known reac-
tions to application of cyclic nucleotides and activation
of the PKC pathway [28]. At concentrations of 1 to 100
nM of TPA (Figure 2D), these cells showed a two fold
increase of their cell migration velocity.
Dynamic regulation of intracellular cyclic nucleotide
levels plays a key role in modulating cellular motility
and regeneration in the nervous system [19,20]. Ad-
ditionally Windus et al. reported that OEC motility re-
gulates activity of pioneer growth cones and therefore
neurite elongation in a positive manner [33]. To explore
a potential involvement of cAMP and cGMP signal
transduction in glial motility, we tested whether mem-
brane permeable nucleotide analogues might facilitate
the closure of the gap. For this purpose we seeded the
cells into 24-well-plates and performed a scratch wound
to the confluent cell monolayer using a pipette tip(Figure 1A). Both pharmacological agents were applied
to the scratch wound assay using concentrations of up
to 500 μM of the membrane permeable cAMP analogue
8-Br-cAMP (Figure 3). Migration rates of OB-OECs in-
creased slightly to 122% and 127% of control at 10 μM
and 100 μM, respectively (Figure 3A). However, this in-
crease was not statistically significant. For Schwann cells
and OM-OECs no increase of migration rates could be
observed (Figures 3B and C). Even the highest concen-
tration of 500 μM 8-Br-cAMP had no stimulatory effect
on cell migration. Next we tested the cGMP/PKG path-
way which has been shown to stimulate NT2 cell mig-
ration [28] (Figure 3D-F). Application of the cGMP
analogue 8-Br-cGMP had no significant effects on cell
migration in all three glial cultures at concentrations
from 10 to 500 μM.
Treatment of glial cell cultures with all chemical
agents including the cell permeable nucleotide analogues
8-Br-cGMP and 8-Br-cAMP or the PKC activator TPA,
did not affect cell viability, even at the highest applied
concentration (Figure 4).
Phagocytic activity of OECs
Recent studies suggested that olfactory ensheathing cells
may be the primary innate immunocytes in the olfactory
Figure 3 Membrane permeable analogues 8-Br-cAMP and 8-Br-cGMP do not increase glial cell migration in a scratch wound assay.
(A-C) Incubation of canine olfactory ensheathing cells and Schwann cells with 8-Br-cAMP (D-F) or 8-Br-cGMP showed no significant increase of
glial migration rate after 8 hours. (A) Ensheathing cells from the olfactory bulb showed a slight increase to 125% of control at 10 μM to 500 μM
8-Br-cAMP. However, this effect was not significant. (B-C) OM-OECs and Schwann cells showed no increase under cAMP treatment. (D-F)
Ensheathing cells from the olfactory bulb showed a slight, not statistically significant increase to 120% compared to controls, at 10 μM 8-Br-cGMP
whereas OM-OECs and Schwann cells showed no change in migration rate under cGMP treatment. Histograms present means ± SEM of 4
separate experiments (all cell types for 8-Br-cAMP) and 4 (OB-OECs, OM-OECs) and 3 (Schwann cells) for 8-Br-cGMP. Statistical analysis was performed
using an ANOVA and the Newman-Keuls post-hoc test.
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activity of the canine glial cells, we examined whether
they could internalize YG fluorescent microspheres of
1 μm diameter. After addition of microspheres to glial
cells seeded on poly-L-lysine coated chamber slides, pha-
gocytosis could be observed for OB-OECs (Figure 5A),
OM-OECs (Figure 5B) and Schwann cells within two
hours of cell culture (Figure 5C). All cells showed at least
six microspheres located in the cytoplasm of the cells,
confirmed by confocal z-stacks. Glial cells incubated in4°C cold culture medium showed changes in their
morphological appearance and did not internalize the
microspheres. Cells cultured at 4°C failed to engulf micro-
spheres (data not shown). To investigate how the distinct
glial cell types would affect healthy neurons, we prepared
co-cultures with cell tracker green CMFDA labeled
human NT2 neurons (Invitrogen, Karlsruhe, Germany).
Under normal cell culture conditions, all of the different
canine glial cells showed no evidence for phagocytosis and
engulfment of neurons (data not shown).
Figure 4 Influence of nucleotide analogues 8-Br-cAMP,
8-Br-cGMP, and the PKC activator TPA on glial cell viability.
(A) The highest concentration of 500 μM of the cGMP analogue
8-Br-cGMP had no significant effect on cell viability of olfactory
ensheathing cells and Schwann cells. Schwann cell showed a slightly
decreased viability (86% of control) which was not significant. (B)
OB-OECs and OM-OECs showed no significant difference between
viability of controls at a concentration of 500 μM 8-Br-cAMP. Schwann
cells showed a significant decrease in cell viability of 81% compared to
controls. (C) Cell viability of all three cell types was not significantly
decreased at 100nM TPA treatment in comparison with control.
Histograms present the means ± SEM of 3 separate experiments with
at least three wells per experiment. Statistical analysis was performed
using an ANOVA and the Newman-Keuls post-hoc test (*p < 0.05).
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outgrowth of developing human neurons
To analyze potential interactions between the isolated
olfactory ensheathing and Schwann cells with neurons,
we measured how canine glial cells influence parameters
of neurite outgrowth. We co-cultured developing human
NT-2 neurons after two weeks of retinoic acid treatment
(2wk RA) [35] together with ensheathing cells from
the olfactory bulb (OB-OECs), the olfactory mucosa
(OM-OECs) and Schwann cells from the fibular nerve.
Outgrowing neurites of the developing neurons were visu-
alized by immunofluorescence, using an antibody against
the neuronal cytoskeletal marker β-III-tubulin.
Seeding of 2wk RA neurons to laminin, PDL coated
culture wells, and a confluent layer of canine glia re-
sulted in the growth of long processes. These extending
neurites stained for β-III-tubulin, while olfactory en-
sheathing (OB-OECs, OM-OECs) and Schwann cells did
not express immunoreactivity (Figures 6A-C). After 24 h
outgrowth most of the neurons showed one long major
neurite and up to five shorter processes emanating from
the cell body. Neurons on PDL extended a shorter major
neurite compared to neurons plated on laminin. Out-
growth on Schwann cells resulted in similar major neu-
rite lengths as for neurons on a PDL coating which was,
however, significantly shorter than for neurons on lam-
inin only (Figures 6A and D). The longest major neurite
could be observed for neurons cultured on OB-OECs.
However, the neurite extension was not significantly lar-
ger than on the laminin coating alone (Figure 6D).
Next we looked at the total length of all neurites
per neuron and found a significantly enhanced total
length for neurons grown on laminin compared to
PDL (Figure 6E). Developing 2wk RA neurons seeded
to Schwann cells and OM-OECs showed the same
total length of neurites compared to neurons grown
on Laminin. The use of OB-OECs as substrate for neurite
outgrowth resulted in the largest effect on total length
with an increase of up to 129% compared to laminin-
coated control. The overall neurite length was significantly
Figure 5 Glial phagocytosis of microspheres. Canine glia showed phagocytosis of microspheres. OB-OECs (A), OM-OECs (B) and SCs (C)
contained 6 to 18 microspheres as indicated by confocal z-axis series analysis. XY, XZ, and YZ projections revealed that the microspheres were
taken up and engulfed by the canine glia. OB-OECs, OM-OECs and Schwann cells incubated 2 h at 4°C showed no signs of engulfed microspheres
indicating that phagocytosis is absent at low temperature (data not shown). Cells are stained against p75NTR (red) and DAPI (blue). YG microspheres
appear cyan due to fluorescence in the blue and green spectrum. Scale bar is 10 μm.
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cells or ensheathing cells from the olfactory mucosa
(OM-OECs, Figure 6D and E). Next we focused on
the initiation and outgrowth of primary neurites. Cultur-
ing the 2wk RA neurons on canine glia resulted in an in-
crease in neurite number for Schwann cells (p < 0.05),
OM-OECs and OB-OECs (both, p < 0.001) compared to
controls on laminin or PDL (Figure 6A-C and F).
To reveal age-dependent neuron intrinsic mechanisms
that might affect neurite formation, we repeated the
same experiments with mature human neurons (hNT2).
There was indeed a remarkable difference compared to
the results of the developing 2wk RA neurons. Evaluat-
ing the longest neurite per neuron, we could only detect
a significant effect between outgrowth on PDL (Figure 6J,
82% of control) and outgrowth on OB-OECs with 105%
of control (Figure 6I). Neither outgrowth on Schwann
cells (96% of control) nor on OM-OECs (94% of control)
resulted in an elongated major neurite compared with
outgrowth on a laminin coating only (Figure 6J). Next
we analyzed the total neurite length of all neurites per
neuron for all five outgrowth substrates. Outgrowth on
PDL (82%), SCs (94%) and OM-OECs (91%) resulted ina not significant reduction of neurite lengths (Figure 6K).
Neurons grown on OB-OECs formed significant longer
neurites compared with PDL, but not with the laminin
coating (Figure 6I and K). To check whether this elon-
gated neurite length is due to the increase in the number
of processes, we counted for each substrate the number
of neurites per neuron. NT2 neurons grown on laminin
formed on an average 2.6 neurites per neuron whereas
PDL coating resulted in 2.4 neurites (Figure 6). Overall,
there was no significant difference in neurite formation
between neurons grown on laminin or PDL compared to
co-culture with Schwann cells (2.4), OM-OECs (2.1) and
OB-OECs (2.4).
Discussion
Assays for cellular functions of purified canine OECs
Olfactory ensheathing cells have claimed to be a unique
cell type according to their special localization in the
PNS and CNS as well as their special morphology known
for their ability to bridge the gap between the central ner-
vous (CNS) and the peripheral nervous system (PNS) in
the mammalian olfactory neuraxis [36-38]. Several studies
have reported beneficial effects on neuronal regeneration
Figure 6 Olfactory ensheathing cells promote neurite outgrowth of developing, but not mature NT2 neurons. Human developing
neurons (2wk RA) were co-cultured with Schwann cells (A) and ensheathing cells from the olfactory mucosa (B) and the olfactory bulb (C) for
24 h. (D) OB-OECs showed a permissive effect for elongation of the longest neurite compared with PDL, Schwann cells and OM-OECs but not
with laminin. (E) Neurite outgrowth on OB-OECs resulted in a significant increase of total length compared with all other substrates and cell
types. (F) Number of neurites is increased for neurons seeded to Schwann cells, OM-OECs and OB-OECs but not for neurons seeded to a laminin
or PDL coating. (G-I) Mature neurons grown on canine Schwann cells (G), mucosal (H) and bulbar ensheathing (I) cells. (J) Elongation of the
major neurite was not significantly increased when seeded to canine glia (K) Total length of neurites was neither affected by glial cells when
compared with control (L) Number of neurites appeared slightly, but not significantly reduced for neurons grown on OM-OECs. Cells were fixed
and stained for β-III-Tubulin (magenta) and DAPI (cyan) after 24 h of co-culturing. Histograms present the means ± SEM of 4–5 experiments (2wk RA)
and 2–3 experiments (hNT2). Statistical analysis was performed using Kruskal-Wallis-test (***p < 0.001, **p < 0.01, *p < 0.05). Scale bar is 50 μm.
Roloff et al. BMC Neuroscience 2013, 14:141 Page 8 of 14
http://www.biomedcentral.com/1471-2202/14/141after OEC transplantation into animals with different
lesion paradigms in the PNS [39-41] and CNS [5,42-44].
Except for a few studies, the majority of investigations
concerning the regenerative potential of ensheathing glia
have been performed in rodent models [9,45-47]. Only afew studies used canine or porcine ensheathing cells as
translational model or even human ensheathing cells to
show differences to rodents [4,5,48-51].The present study
is one of the first to utilize a comparative approach for
analysis of the migratory, phagocytic and neurite growth-
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rations of OECs and Schwann obtained from a large ani-
mal model [18].
Olfactory ensheathing cell and Schwann cell migration
To test for differences in migratory capabilities, we per-
formed a scratch wound assay over the rather short time
interval of 8 hours. Therapeutic treatment of SCI clearly
would require longer migration times in the range of
weeks. However, the rather short migration time of 8 h
is a concession to the simplicity of the in vitro test sys-
tem. We have performed a cell proliferation assay and
found less than 20% BrdU-positive cells at 8 h of incuba-
tion. A significant effect of proliferation on the motility
component of the scratch wound assay could therefore
be excluded. Comparative analysis revealed a striking
difference in migratory capacities of OB-OECs, OM-
OECs and SCs. Former studies have reported either
a difference in migration rates between OECs and
Schwann cells in the X-radiated spinal cord [52] or no
difference between these cells after transplantation in a
spinal cord injury model [53]. The occurrence of lamelli-
podial waves and the density of cells are reported to in-
fluence the rate of in vitro migration [54]. However,
most of the studies agree that migration within the in-
jured spinal cord is essential to establish a permissive
environment to promote sprouting and inhibit scar
formation [45,55-57]. So far, in vitro migration rates of
SC-free cultures of OECs obtained from the olfactory
bulb and mucosa have not been compared to Schwann
cells in a scratch wound assay. This study shows that
SC-free cultures of canine OECs from the olfactory bulb
migrate faster than OECs from the mucosa or Schwann
cells from the tibial nerve (Figure 1G). Moreover, activa-
tion of the protein kinase C by phorbol ester treatment
significantly promoted migration of canine OECs. This
was also found for the human NT2 cell line. The ab-
sence of a response to phorbol ester treatment in ca-
nine Schwann cells indicated a differential expression
of signal transduction pathways regulating migratory
behavior in ensheathing compared to peripheral glial
cells. A former study of Simón et al. reported that
inhibiting PKC resulted in a decreased expression of
PAI-1 in human OECs associated with a reduced
OEC-dependent regeneration of axons of adult retinal
ganglion cells [58].
Rodent OECs showed an increase in proliferation, ex-
pression of GFAP and a morphology change of OECs
upon the cAMP-elevating agent Forskolin, whereas pri-
mate OECs lacked such a response [48].
Activation of the cAMP/PKA pathway overcomes the
regeneration inhibitory effects of myelin in vitro and
neuritogenesis of human NT2 neurons is elevated af-
ter treatment with cAMP [35]. Therefore, to improveensheathing glia migration we applied 8-Br-cAMP [35,59].
Though Wang and Huang and Vincent et al. showed a
change of the glia morphology from an astrocyte-like to a
Schwann cell-like cell type under elevated levels of cAMP,
we could not observe any morphological difference to
cells cultured under control conditions [60,61]. In line
with this observation, culturing canine glia with 8-Br-
cAMP did not change the glial cell migration rate
(Figure 3A-C). Culturing OECs in the presence of low
concentrations or the absence of serum resulted in a
shift from a flattened to a more spindle-shaped cell
morphology [61]. The absence of cAMP-mediated effects
for canine OECs was already shown by Techangamsuwan
et al. and supports observed differences in migratory
properties of human and canine OECs compared to ro-
dent OECs [48].
Similarly, the nucleotide cGMP, known to facilitate
migration of human NT2 neurons, fetal human neu-
ral progenitor cells and human bronchial epithelial
cells [28,62,63] did not enhance canine glia migration
(Figure 4).
Phagocytic activity of ensheathing glia
During normal olfactory neuron turnover, OECs remove
debris of dead receptor cells by phagocytosis [15,17].
Moreover, recent studies showed, that OECs and Schwann
cells represent the first defence mechanism of the nasal
cavity and they react upon contact to bacteria [16,34,64].
Along with this function, activation of OECs with lipo-
polysaccharides (LPS) resulted in a strongly increased
phagocytic activity consisting of ingestion of apoptotic
cell fragments in vitro and in vivo. The remains of de-
graded olfactory receptor neurons (ORNs) are known to
block axonal regeneration and outgrowth of new ORNs
in general [65,66]. In the nasal mucosa, apoptotic ORNs
and cell debris like O4+ fragments are engulfed by
OECs and removed from the olfactory pathway [15].
OECs injected into the subretinal space in a retinitis
pigmentosa model [67] or a demyelinating spinal cord
model of rats, cleaned the subretinal space from accu-
mulated debris or phagocytized degenerated host tissue.
This has also been found in intracranial sections of rat
olfactory bulbs [68].
Culturing both canine OECs and Schwann cells with
1 μm microspheres resulted in engulfment and their
localization into the cell within two hours (Figure 5).
This could be prevented by slowing down the cell me-
tabolism at 4°C. The phagocytosis of the microspheres
by cultured canine glia resembles the removal of small
cellular debris. In contrast, co-culturing of intact human
NT2 neurons without any indications of apoptosis to-
gether with canine ensheathing glia for 24 hours pro-
vided no evidence for a phagocytic uptake of fluorescent
neuronal material.
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In the present study, we show for the first time, that ca-
nine ensheathing glia promote neurite outgrowth of de-
veloping human model neurons (Figure 6). Culturing
developing NT2 neurons on a substrate of canine en-
sheathing glia from the PNS and CNS resulted in an
increased sprouting and elongation of neurites. The
positive interaction between canine cells and human
model neurons is also in support of a concept using dogs
as a translational model for the development of neural
repair strategies in human patients [5,18,50,69].
Previously, we showed a preferential growth of dorsal
root ganglion (DRG) neurons on canine OM-OEC, OB-
OECs and Schwann cells [70]. Comparative analysis re-
vealed that neurite length of DRG neurons and numbers
of branching points were significantly increased when
co-cultured with OM-OECs instead of OB-OECs and
Schwann cells, respectively. Nevertheless, DRG neurons
growth on OB-OECs and Schwann cells was improved
compared to OM-OECs. DRG neurons cultured together
with OM-OECs tended to stick to the poly-L-lysine sub-
strate more firmly than to the cell surface of the glial
cells. Using differentiating NT2 neurons we obtained an
overall beneficial effect of canine OB-OECs, OM-OECs
and SCs compared to a poly-D-lysine or the permissive
laminin control. The number of neurites was higher in
co-cultures of canine glia compared to both poly-D-lysin
and laminin controls. These findings indicate that canine
glia support the initiation of primary neurites and the
elongation of these neurites. Due to the rather confluent
glia cell layer, we could not directly evaluate whether co-
cultured human NT2 neurons were directly associated
to canine glia or the underlying substrate. Thus we can-
not distinguish whether the growth promoting effects
are due to soluble factors or direct contact to the glial
cell surface.
The results obtained from NT2 neurons differ from
results obtained after co-culturing rat DRG neurons with
the same canine glial cells in a previous study [70]. DRG
neurons are a unique type of neurons projecting two
axonal branches; therefore reported differences could be
neuron specific. Dorsal root ganglion neurons exhibit a
centrally projecting branch extending into the spinal
cord and the peripheral branch projecting through a per-
ipheral nerve [71]. DRG neurons showed regeneration
when the peripheral branch was lesioned first, but failed
to regenerate when the central branch was lesioned [72].
Fudge and Mearow reported that a dissociated DRG
culture is a heterogeneous mixture of different neuron
phenotypes showing various responses to a permissive
environment [73]. The close resemblance of the DRG
entry zone and the olfactory bulb, both displaying a
bridge between PNS and CNS, encouraged Ramón-
Cueto and Nieto-Sampedro to use DRG neurons as a“proof of principle” for the regeneration facilitating ef-
fects of OECs [74]. In contrast to DRG neurons, human
model neurons of the present study resembled more
closely the CNS phenotype [35,75-77] which might ac-
count for the neuron specific differences between this
and our former study [70].
The regenerative capacity of neurons is strongly
reduced with age [78]. To account for this neuron-
intrinsic limitation of neurite regeneration, we performed
the co-culture experiments with NT2 neurons of mature
developmental stage [75,76]. There was indeed a remar-
kable difference to the results of the developing 2wk RA
neurons (Figure 6). Using mature neurons, there was only
a weak increase between outgrowth on OB-OECs and out-
growth on PDL control and no positive effect on neurite
formation for the other glial co-culture conditions. The
reduction in regeneration between the 2wk RA and the
mature neurons on glial co-cultures suggested that NT2
model neurons can mimic the loss in regenerative cap-
acity that is generally observed in experimental animal
models [1,2,79,80]. This does not necessarily imply that
glial transplantations into mature neural tissue are in-
effective to treat spinal injury. The reported beneficial
effects of OEC transplantations into the injured spinal
cord might result from clearance of cellular debris,
axon guidance by migrating OECs, and the formation
of tunnel-shaped pathways for regenerating axons
[10,45,52,81,82]. In summary, co-cultures of canine
glia and NT2 neurons appear to mimic cellular mech-
anisms of neural regeneration in damaged nerve tis-
sue, comprising a useful platform for screening novel
neuroprotective agents.
Conclusions
This in vitro study supports the therapeutic approach
that OEC and Schwann cell transplantation into the
spinal cord generates a permissive environment for re-
generation in the central nervous system. We demon-
strate differences of ensheathing glial cell types with
respect to migration and neurite outgrowth from neu-
rons. OECs from the olfactory bulb migrate faster and
enhance neurite growth of human model neurons better
than OECs from the mucosa and Schwann cells. We
challenged various signal transduction pathways with
enzyme activators and show that stimulation of the
protein kinase C pathway enhances migration of OECs
from the olfactory bulb. Moreover, we demonstrate for
the first time, that canine ensheathing glia promote
neurite outgrowth of developing human model neurons.
Methods
All test substances were diluted in Dulbecco’s modified
Eagle medium (canine glia, DMEM Gibco-Invitrogen,
Karlsruhe, Germany) or DMEM/F12 (NT2 cells, Gibco-
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trogen), 1% penicillin and streptomycin. The cAMP
analogue 8-Br-cAMP (8-Bromoadenosine 3′,5′-cyclic
monophosphate), the cGMP analogue 8-Br-cGMP
(8-Bromoguanosine 3′,5′-cyclic monophosphate) were
purchased from Sigma (Taufkirchen, Germany). The pro-
tein kinase C activator 12-O-tetradecanoylphorbol-13-
acetate purchased from Alomone Labs (Jerusalem, Israel).
Unless stated otherwise, all chemicals were obtained
from Sigma.
Cell cultures
All animals used for cell isolation were treated according
to the legal and ethical requirements of the University of
Veterinary Medicine Hannover (Germany). The proce-
dures complied with the guidelines of animal welfare as
laid down by the German Research Council (DFG). Puri-
fied primary OEC and Schwann cell cultures were gene-
rated as described previously [18].
OM-OEC cultures were isolated from the caudal re-
gions of the nasal septum and conchae. All Schwann
cells were removed immediately from primary cell
suspensions by using anti-HNK-1 (OM-OECs) and anti-
p75NTR antibodies (OM-OECs, OB.OECs) and magnet-
activated cell sorting (MACS; Miltenyi Biotec, Bergisch
Gladbach, Germany). Schwann cells were obtained from
the fibular nerve after removal of the epineural sheath
[83]. Trypsin, hyaluronidase type IV, and collagenase type
XI (0.5% each, Sigma Aldrich, Taufkirchen, Germany)
were used to digest nerve preparations after 5–7 days of
pre-degeneration in vitro by incubating nerve fibers [18].
Canine glia were cultured in T75 culture flasks with
DMEM containing additionally 20 ng/ml recombinant
human FGF-basic (fibroblast growth factor, Peprotech).
Cells were trypsinized (Trypsin-EDTA, PAA, Marburg,
Germany) twice a week and transferred to new T75 flasks
and cultured under standard conditions (37°C, 5% CO2).
Purity of glia cell cultures was about 95% as earlier re-
ported in Ziege et al. [18]. NT2/D1 precursor cells (NT2)
were purchased from the American Type Culture Col-
lection (ATTC, Manassas, VA20108, USA). Neuronal dif-
ferentiation was done as previously described [75,76].
After grown to confluence NT2 precursor cells were tryp-
sinized (Trypsin-EDTA, Gibco-Invitrogen) and cultured
in 95 mm, bacteriological grade Petri dishes (Greiner,
Hamburg, FRG) at a density of 5 × 106 cells/dish in 10 ml
Dulbecco’s modified Eagle medium (DMEM/F12,) supple-
mented with 10% fetal bovine serum, 1% penicillin and
streptomycin and 10 μM retinoic acid to start neuronal
differentiation. After 7–10 days, cells were trypsinized
again and transferred to T75 culture flasks with retinoic
acid at a density of 4 × 107 cells / flask. After additional
7–10 days, cells were trypsinized and cultured 2 days with
DMEM/F12 until they were transferred to T175 flaskswith DMEM/F12 containing mitotic inhibitors (1 μM 1-6-
D-arabinofuranosylcytosine, 10 μM 2′-deoxy-5-fluorouri-
dine and 10 μM 1-β-D-ribofuranosyluracil). During
culturing of cells with medium containing mitotic in-
hibitors, neurons became visible after 7–10 days. Neurons
were selectively trypsinized, counted and used in up-
coming experiments. Neurons termed as 2wk RA repre-
senting a model for developing human neurons were
cultured for additional 7 days with 10 μM retinoic
acid in petri dishes instead of being transferred to
T175 flasks with inhibitor medium [35]. After two
weeks of retinoic acid treatment in petri dishes cells
were dispersed, counted and used for neurite out-
growth experiments.For all cell culture experiments,
canine glia of passage 7 (OB-OECs, OM-OECs and
SCs), 2wkRA neurons of passage 20–30 and hNT2
passage 22–31 were used.
Scratch wound assay
Migration of glial cells (passage 7) and human NT2 pre-
cursor (passage 22–30) cells was measured by the
scratch wound assay as described by Liang et al. [27].
Olfactory ensheathing cells, Schwann cells and NT2 pre-
cursor were plated at a density of 150.000 -200.000 cells
to poly-L-lysine coated (glia) and uncoated (NT2 pre-
cursor) 24-well-plates (Corning Costar, Kaiserslautern,
Germany) 24 hours prior to the scratch. The next day a
cell free area spanning approximately 600 μm in dia-
meter was scratched using a crystal 10 μl pipette tip
(Figure 1A). The wells were washed with medium to re-
move cellular debris. Cells were incubated with DMEM
(canine glia) or DMEM/F12 (NT2) containing the cGMP
analogue 8-Br-cGMP (10, 100, 500 μM), the cAMP
analogue 8-Br-cAMP (10, 100, 500 μM) and PKC acti-
vator phorbol-12-myristate 13-acetate (TPA, 1, 10, 100
nM). The scratch was photographed 0 h and 8 h after its
generation using a Zeiss Axiovert 200 microscope equip-
ped with a Cool Snap camera (Photometrics, Tucson,
Ariz., USA) and Meta Morph software (Molecular De-
vices, Sunnyvale, Calif., USA). Gap width was measured
using ImageJ 1.46d (NIH, http://rsbweb.nih.gov/ij/, USA).
The distance was calculated by subtracting the average
gap width after 8 h from the average gap width at 0 h di-
vided by 2 (Figures 1E and F). BrdU incubation caused
the labelling of only a few cells in the scratch wound
(data not shown). Due to the short time interval of 8 h,
we can rule out a significant contribution of cell prolifer-
ation to the closure of the gap. Contrast enhancement
and image overlay was done with ImageJ.
Phagocytosis assay
Phagocytic activity was determined for olfactory en-
sheathing cells and Schwann cells in vitro using latex
microsphere beads. Glial cells were seeded to poly-L-
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Slides™ (Sigma-Aldrich, Taufkirchen, Germany) at a
density of 30,000 cells per well. Cells were incubated at
37°C and 5% CO2 in DMEM medium containing 5%
FBS. After 12 hours yellowgreen fluorescent fluoresbrite
carboxylated microspheres (1 μm diameter, Polysciences
Europe GmbH, Eppelheim, Germany) were coated with
FBS for 60 minutes at room temperature before they
were diluted with DMEM medium to a final concen-
tration of 2.8×107 microspheres/ well. After 60 to 120
minutes at 37°C in the incubator, cells were fixed with
4% PFA (paraformaldehyde) for 15 minutes at room
temperature. Remaining microspheres were rinsed off
with PBS and 0.1% Triton X-100. As a negative control
glial cells were incubated at 4°C. Afterwards Chamber
Slides™ were stained for p75NTR and 4′,6-diamidino-2-
phenylindole (DAPI, Invitrogen, Karlsruhe, Germany) to
determine co-localization of YG microspheres and glial
cells. Phagocytized microspheres were localized taking
z-axis series of single cells on the Chamber Slides™,
using a Leica TCS SP5 AOBS confocal microscope.
Using the confocal series we created XY, XZ and YZ im-
ages to check whether the microspheres are located on
the inside of the cell or on the exterior (Figure 5).
Neurite outgrowth assay
To monitor effects of glial cells on neurite outgrowth of
human neurons we seeded hNT2 (passage 22–31) neu-
rons and 2wk RA (passage 23–30) neurons on different
substrates. As control coatings we used poly-D-lysine
(10 μg/ml) and poly-D-lysine/laminin (100 μg/ml). Glial
cells of passage 7 were seeded 1 hour prior to neuron
seeding at a density of 25,000 cells/well to poly-L-lysine
coated 96-well-plates (Corning Costar, Kaiserslautern,
Germany). After attachment of glial cells to the sub-
strate, neurons were seeded at a density of 10,000 cell/
well to the OB-OECs, OM-OECs and the Schwann cells
with a 1:1 ratio of DMEM and DMEM/F12 medium.
Neurons, cultured for 24 h under 37°C and 5% CO2,
were fixed and stained for β-III-Tubulin to evaluate the
neurite outgrowth. For each neuron all neurites were
measured using ImageJ. Furthermore the longest neurite
and number of extending processes for each neuron
were determined. For evaluation of the effect on neurite
outgrowth only neurons with an apparent neurite were
taken into account. Each experiment was performed at
least in six wells and repeated three to five times with at
least 74 neurons (2wkRA neurons) and 50 neurons
(hNT2 neurons), per experiment, respectively.
Immunocytochemistry
Immunocytochemistry was performed on mature hNT2
neurons and dispersed 2wk RA neurons as previously
described [28]. Human neurons were fixed with 4% PFAand permeabilized with 0.1% Triton X-100. The monoclo-
nal antibody β-III-Tubulin (1:10000, Sigma, Taufkirchen,
Germany) was applied overnight at 4°C. The biotinylated
secondary antibody (Vector, Burlingame, Mass., USA) was
applied for at least 1 h at room temperature before Strep-
tavidin coupled Cy3 was added for 1 h at room tem-
perature to detect immunofluorescence. Nuclei were
visualized using DAPI (4′6-diamidino-2′henylindoldi-
hydrochloride, 0.1 μg/ml, Sigma, Taufkirchen, Germany)
as counterstain.Statistical analysis
Graph Pad Prism was used for statistical evaluation. Data
are expressed as the mean ± SEM. Significant differences
were determined by one-way-ANOVA and the Newman-
Keuls Multiple Comparison Test (scratch wound assay) or
the Kruskal-Wallis Test and the Dunns Test (neurite out-
growth assay). Quantitative results are usually based on
3–5 independent experiments performed at least in tripli-
cate. Significant levels are: * < 0.05, ** < 0.01, *** < 0.001.
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